[1-(2-bromophenyl)cyclopropyl]methanamine, 97%, 250mg

2,5-Dichlorophenylsulfonylethanol, 98.0%, 1g

{[(3-fluorophenyl)sulfonyl]amino}acetic acid, 95.0%, 500mg

3-Methyl-1,2,3,4-tetrahydroquinoline, 95.0%, 10g

(R)-(-)-1-(2-Pyrrolidinylmethyl)pyrrolidine, 95.0%, 5g

2-Cyclopropylnicotinic acid, 1g

Ascorbic acid, 99.00%, 25g

2,5-Dimethylphenylacetic Acid>98.0%(GC)(T)25g

MagSi-STA Trial kit

2-Piperidin-3-yl-propan-2-ol, 95.0%, 1g

1H,1H-Heptafluoro-n-butyl methacrylate, 97.0%, 5g

N-(Piperidin-4-ylmethyl)methanesulfonamide hydrochloride, 95.0%, 1g

5-Bromo-2,3-difluorophenol, 98.0%, 5g